VivaCell Biotechnology Espana SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:VivaCell Biotechnology Espana SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12364
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VivaCell Biotechnology Espana SL (VivaCell Biotechnology), a subsidiary of VivaCell Biotechnology GmbH, is a preclinical-stage pharmaceutical company that develops medicinal derivatives. The company’s products comprise CDE-001, VCE-003.2 and VCE-004.8. It provides research and development, consulting and biotechnological platforms in the areas of metabolic syndrome and obesity, dermatology and dermo-cosmetic, immunology and inflammation, cancer, inflammation and cancer animal models and neuro-inflammation. VivaCell Biotechnology products are used in the treatment of fibrotic disease, Parkinson’s disease, skin infections, amytrotrophic lateral sclerosis and chronic inflammatory diseases. VivaCell Biotechnology is headquartered in Cordoba, Spain.

VivaCell Biotechnology Espana SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
VivaCell Biotech Enters into Agreement with Emerald Health Pharma 10
Aphios Enters Into Research Agreement With VivaCell To Develop CNS Therapeutics 11
Licensing Agreements 12
Indena Enters Into Licensing Agreement VivaCell Biotech 12
Equity Offering 13
VivaCell Biotechnology Espana Raises USD3.5 Million in Private Placement 13
Acquisition 14
Emerald Health Sciences Acquires 10% Stake in VivaCell 14
Phytoplant Research Acquires Minority Stake In VivaCell Biotech 15
VivaCell Biotechnology Espana SL – Key Competitors 16
VivaCell Biotechnology Espana SL – Key Employees 17
VivaCell Biotechnology Espana SL – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Key Facts 2
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VivaCell Biotechnology Espana SL, Deals By Therapy Area, 2012 to YTD 2018 8
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
VivaCell Biotech Enters into Agreement with Emerald Health Pharma 10
Aphios Enters Into Research Agreement With VivaCell To Develop CNS Therapeutics 11
Indena Enters Into Licensing Agreement VivaCell Biotech 12
VivaCell Biotechnology Espana Raises USD3.5 Million in Private Placement 13
Emerald Health Sciences Acquires 10% Stake in VivaCell 14
Phytoplant Research Acquires Minority Stake In VivaCell Biotech 15
VivaCell Biotechnology Espana SL, Key Competitors 16
VivaCell Biotechnology Espana SL, Key Employees 17

List of Figures
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VivaCell Biotechnology Espana SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[VivaCell Biotechnology Espana SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bank of America Corp:企業の戦略・SWOT・財務情報
    Bank of America Corp - Strategy, SWOT and Corporate Finance Report Summary Bank of America Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nationwide Building Society:企業のM&A・事業提携・投資動向
    Nationwide Building Society - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nationwide Building Society Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Bayshore Petroleum Corp (BSH):企業の財務・戦略的SWOT分析
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. It utilizes CCC technology for heavy oil a …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Lietuvos energijos gamyba AB (LNR1L):企業の財務・戦略的SWOT分析
    Lietuvos energijos gamyba AB (LNR1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ASX Ltd (ASX):企業の財務・戦略的SWOT分析
    ASX Ltd (ASX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Aquestive Therapeutics Inc (AQST):製薬・医療:M&Aディール及び事業提携情報
    Summary Aquestive Therapeutics Inc (Aquestive Therapeutics) is a pharmaceutical company that discovers, develops and commercializes prescription drug products and a pipeline of prescription formulations. The company offers PharmFilm a drug delivery platform that delivers existing prescription produc …
  • The Emirates Group:企業の戦略・SWOT・財務分析
    The Emirates Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Millicom International Cellular SA (MIC SDB):企業の財務・戦略的SWOT分析
    Millicom International Cellular SA (MIC SDB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Hyundai Corporation:企業の戦略・SWOT・財務情報
    Hyundai Corporation - Strategy, SWOT and Corporate Finance Report Summary Hyundai Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Huesker Synthetic GmbH:企業の戦略・SWOT・財務情報
    Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report Summary Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hon Hai Precision Industry Co Ltd (2317):企業の財務・戦略的SWOT分析
    Hon Hai Precision Industry Co Ltd (2317) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Smith & Nephew plc:企業のM&A・事業提携・投資動向
    Smith & Nephew plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smith & Nephew plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Blueberry Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea ped …
  • Thermal Energy International Inc (TMG):企業の財務・戦略的SWOT分析
    Summary Thermal Energy International Inc (Thermal Energy) is a cleantech company. The company supplies proprietary energy efficiency and emission reduction solutions to industrial and institutional sectors. Its products include GEM steam traps, FLU-ACE heat recovery systems, Dry Rex biomass dryer, a …
  • GlaxoSmithkline Consumer Healthcare Ltd:企業の戦略・SWOT・財務情報
    GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report Summary GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Lycatel Services Ltd:企業の戦略的SWOT分析
    Lycatel Services Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Davide Campari-Milano SpA:企業の戦略・SWOT・財務情報
    Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report Summary Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Hoteli Maestral d.d.:企業の戦略・SWOT・財務情報
    Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report Summary Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Performance Food Group:企業の戦略・SWOT・財務情報
    Performance Food Group - Strategy, SWOT and Corporate Finance Report Summary Performance Food Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆